A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors

Filip Janku, Milind M. Javle, Shiraj Sen, Shubham Pant, Lindsay G. Bramwell, Vivek Subbiah, Tracey Way, David S. Wages, Catherine A. Wheeler, Takeaki Suzuki, Kazunori Saeki, Ruth Ann Subach, Timothy Madden, Gary Maier, Mary J. Johansen, Kin Cheung, Gerald S. Falchook

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences